GlobeNewswire
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
📈
AI Sentiment
Highly Positive
8/10
- Home
- PMN
as of 12-12-2025 2:05pm EST
$8.76
+$0.00
+0.05%
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Chart Type:
Time Range:
| Founded: | 2004 | Country: | Canada |
| Employees: | N/A | City: | TORONTO |
| Market Cap: | 23.5M | IPO Year: | N/A |
| Target Price: | $72.67 | AVG Volume (30 days): | 42.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -20.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.27 - $39.75 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered PMN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 67.13%
67.13%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of ProMIS Neurosciences Inc. (ON) (PMN)
Milbury Max A.
Buy
Other
PMN Oct 3, 2025
Avg Cost/Share
$0.49
Shares
30,392
Total Value
$14,928.55
Owned After
45,389
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Milbury Max A. | PMN | Other | Oct 3, 2025 | Buy | $0.49 | 30,392 | $14,928.55 | 45,389 |
Latest ProMIS Neurosciences Inc. (ON) News
PMN Breaking Stock News: Dive into PMN Ticker-Specific Updates for Smart Investing
Compare PMN vs Leading Stocks
See how PMN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PMN ProMIS Neurosciences Inc. (ON) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.